ClearPoint Neuro Inc. (NASDAQ: CLPT) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT CLEARPOINT NEURO INC.

ClearPoint Neuro Inc. (NASDAQ: CLPT)
Listen to this Section


$13.58
+0.1400 ( +1.04% ) 177.1K

ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.

Market Data


Open $13.58
Previous Close $13.44
Volume 177.1K
Market Cap $403.06M
Day Range $13.27 - $14.27
52 Week Range $8.27 - $30.10
Shares Outstanding 29.99M
Change % +1.04%
Net Change ▲ 0.1400
Insider Ownership 0.00%
Exchange NASDAQ
SectorHealthcare
IndustryMedical/Dental Instruments
IPO Year2012
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -844,521.00

Date Type Amount Purchased Purchaser
2024-07-02 Sale -767.00 SABRA MAZIN
2024-07-02 Sale -1072.00 FLETCHER R JOHN
2024-07-02 Sale -2069.00 Richards Timothy T.
2024-07-02 Sale -3500.00 BURNETT JOSEPH MICHAEL
2024-07-02 Sale -3500.00 STIGALL L. JEREMY
2024-07-02 Sale -1333.00 Girin Pascal E R
2024-07-02 Sale -1913.00 D'Alessandro Danilo
2024-07-02 Sale -550.00 LIAU LINDA M.
2024-06-11 Sale -4824.00 D'Alessandro Danilo
2024-06-11 Sale -14003.00 BURNETT JOSEPH MICHAEL

SEC Filings


Form Type Description Pages Date
schedule Other 1 Nov 12, 2025
144 Insider transactions 1 Nov 12, 2025
8-k 8K-related 44 Nov 06, 2025
10-q Quarterly Reports 54 Nov 06, 2025
8-k 8K-related 13 Nov 06, 2025
4 Insider transactions 1 Oct 14, 2025
4 Insider transactions 1 Oct 14, 2025
4 Insider transactions 1 Oct 02, 2025
4 Insider transactions 1 Oct 02, 2025
4 Insider transactions 1 Oct 02, 2025

Latest News


× Before browsing our site, please accept our cookies policy